Events | 2018.10.03
ABL Awarded Long-Running National Cancer Institute Contract to Continue Groundbreaking Retroviral Research
ROCKVILLE, Md., Oct. 3, 2018 /PRNewswire/ -- ABL, Inc. (ABL), a global contract research and manufacturing service provider, is pleased to announce it was awarded the "Support for Research on Retroviral Pathogenesis, Treatment and Prevention" contract by the National Cancer Institute...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]oviral-research-300723765.html
